Relating to a policy regarding the maintenance, administration, and disposal of medication for respiratory distress by public and private schools.
Impact
The legislation specifically addresses the need for schools to maintain a supply of medication for respiratory distress, including epinephrine auto-injectors. By requiring and standardizing the inventory and training protocols, HB 856 seeks to ensure that schools are prepared to respond effectively to medical emergencies. The executive commissioner of the Health and Human Services Commission will oversee the creation of rules to guide schools in these practices, which could lead to more consistent responses to health emergencies across Texas educational institutions.
Summary
House Bill 856 aims to enhance the health and safety protocols within public and private schools regarding the management of medications for respiratory distress. The bill mandates that each school district, open-enrollment charter school, and private school implement a comprehensive policy that outlines the maintenance, administration, and disposal of respiratory medication. This includes the availability of medications and necessary training for appointed school personnel or volunteers to safely administer these medications to students who might experience respiratory distress, either during school hours or at school-sponsored activities.
Contention
Notably, while the bill seems to promote safety and health, there could be challenges regarding the implementation of training programs and logistical considerations around maintaining medication supplies. There may be discussions concerning the adequacy of funding for these enhancements and whether all schools can realistically meet the new requirements, especially in smaller districts with limited resources. Additionally, questions may arise about the extent of liability schools hold when administering medications, making the balance between preparedness and practicality a central point of contention.
Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Relating to contracting by public and private schools for the provision of medication for respiratory distress and training in administering that medication.